QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 18 December 2002
doi: 10.1242/jcs.00286

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.00286v1 116/4/665    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kiriakidis, S. Articles by Paleolog, E. Search for Related Content PubMed PubMed Citation Articles by Kiriakidis, S. Articles by Paleolog, E.

VEGF expression in human macrophages is NF-B-dependent: studies using adenoviruses expressing the endogenous NF-B inhibitor IB and a kinase-defective form of the IB kinase 2

Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, London W6 8LH, UK

^* Author for correspondence (e-mail: s.kiriakidis{at}ic.ac.uk)

Accepted 20 November 2002

Vascular endothelial growth factor (VEGF) is the most endothelial cell-specific angiogenic factor characterised to date, and it is produced by a variety of cell types. In macrophages, VEGF has been shown to be upregulated by the inflammatory mediator lipopolysaccharide (LPS) and by engagement of CD40 by CD40 ligand (CD40L). Because LPS and CD40L activate nuclear factor-B (NF-B) in monocytes, we investigated in this study whether VEGF production in macrophages, when stimulated with either LPS or CD40L, is NF-B-dependent. We used adenoviral constructs over-expressing either IB (AdvIB), the endogenous inhibitor of NF-B, or a kinase-defective mutant of IKK-2 (AdvIKK-2dn), an upstream activator of IB, to infect normal human monocyte-derived macrophages. We observed that LPS-induced production of VEGF in human macrophages was almost completely inhibited (>90%) following adenoviral transfer of IB. In addition, we observed significant inhibition of the CD40L-induced VEGF production in macrophages following infection with AdvIB. Expression of IKK-2dn in macrophages decreased VEGF production in response to LPS or CD40L by approximately 50%, suggesting that in addition to IKK-2, other kinases might be involved in NF-B activation. These results show for the first time that VEGF production in human macrophages is NF-B dependent. NF-B regulates many of the genes involved in immune and inflammatory responses, and our study adds the angiogenic cytokine VEGF to the list of NF-B-dependent cytokines.

Key words: VEGF, Macrophages, Angiogenesis, NF-B, Signalling, CD40 ligand

This article has been cited by other articles:

				Y. Mizukami, Y. Kohgo, and D. C. Chung Hypoxia Inducible Factor-1 Independent Pathways in Tumor Angiogenesis Clin. Cancer Res., October 1, 2007; 13(19): 5670 - 5674. [Abstract] [Full Text] [PDF]

				R. Gonzalez-Ramos, J. Donnez, S. Defrere, I. Leclercq, J. Squifflet, J.-C. Lousse, and A. Van Langendonckt Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis Mol. Hum. Reprod., July 1, 2007; 13(7): 503 - 509. [Abstract] [Full Text] [PDF]

				B. K. Ray, A. Shakya, and A. Ray Vascular Endothelial Growth Factor Expression in Arthritic Joint Is Regulated by SAF-1 Transcription Factor J. Immunol., February 1, 2007; 178(3): 1774 - 1782. [Abstract] [Full Text] [PDF]

				J. S. Mader, D. Smyth, J. Marshall, and D. W. Hoskin Bovine Lactoferricin Inhibits Basic Fibroblast Growth Factor- and Vascular Endothelial Growth Factor165-Induced Angiogenesis by Competing for Heparin-Like Binding Sites on Endothelial Cells Am. J. Pathol., November 1, 2006; 169(5): 1753 - 1766. [Abstract] [Full Text] [PDF]

				G. T. Stathopoulos, Z. Zhu, M. B. Everhart, I. Kalomenidis, W. E. Lawson, S. Bilaceroglu, T. E. Peterson, D. Mitchell, F. E. Yull, R. W. Light, et al. Nuclear Factor-{kappa}B Affects Tumor Progression in a Mouse Model of Malignant Pleural Effusion Am. J. Respir. Cell Mol. Biol., February 1, 2006; 34(2): 142 - 150. [Abstract] [Full Text] [PDF]

				S. Fujioka, J. Niu, C. Schmidt, G. M. Sclabas, B. Peng, T. Uwagawa, Z. Li, D. B. Evans, J. L. Abbruzzese, and P. J. Chiao NF-{kappa}B and AP-1 Connection: Mechanism of NF-{kappa}B-Dependent Regulation of AP-1 Activity Mol. Cell. Biol., September 1, 2004; 24(17): 7806 - 7819. [Abstract] [Full Text] [PDF]

				R. G. Correa, V. Tergaonkar, J. K. Ng, I. Dubova, J. C. Izpisua-Belmonte, and I. M. Verma Characterization of NF-{kappa}B/I{kappa}B Proteins in Zebra Fish and Their Involvement in Notochord Development Mol. Cell. Biol., June 15, 2004; 24(12): 5257 - 5268. [Abstract] [Full Text] [PDF]

				C. Monaco, E. Andreakos, S. Kiriakidis, C. Mauri, C. Bicknell, B. Foxwell, N. Cheshire, E. Paleolog, and M. Feldmann Canonical pathway of nuclear factor {kappa}B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis PNAS, April 13, 2004; 101(15): 5634 - 5639. [Abstract] [Full Text] [PDF]

				R. Walczak, S. B. Joseph, B. A. Laffitte, A. Castrillo, L. Pei, and P. Tontonoz Transcription of the Vascular Endothelial Growth Factor Gene in Macrophages Is Regulated by Liver X Receptors J. Biol. Chem., March 12, 2004; 279(11): 9905 - 9911. [Abstract] [Full Text] [PDF]

				C. Monaco and E. Paleolog Nuclear factor {kappa}B: a potential therapeutic target in atherosclerosis and thrombosis Cardiovasc Res, March 1, 2004; 61(4): 671 - 682. [Abstract] [Full Text] [PDF]